Trusted Press Release Distribution   Join | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Precision Business Insights
www.precisionbusinessinsights.com
Rajesh k
sales@precisionbusinessinsights.com
Precision Business Insights, Kemp House, 152 – 160 City Road,
EC1V 2NX

Bookmark and Share
Anxiety Disorders and Depression Treatment Market: Market Size, Share,Forecast 2018-2024
Global Anxiety Disorders and Depression Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024


Anxiety Disorders and ...
BriefingWire.com, 5/18/2018 - Global Anxiety Disorders And Depression Treatment Market Was Valued At US $ --Mn In 2017 And Expected To Grow At --% Compound Annual Growth Rate (CAGR) Over 2018 To 2024.

Market Outline: Anxiety Disorders and Depression Treatment Market

Anxiety is a disorder that differ from normal feelings of nervousness or anxiousness. It involves excessive anxiety. Anxiety is a normal reaction to stress. For a patient with anxiety disorder, the anxiety does not lessen but can get worse over the period of time.

Free sample of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/anxiety-disorders-and-depression-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

Market Dynamics: Anxiety Disorders and Depression Treatment Market

Increase in the prevalence of anxiety disorder and depression is majorly driving the growth of the anxiety disorders and depression treatment market. According to the World Health Organization (WHO), in 2017, over 300 million people of all ages globally are suffering from depression, wherein 800,000 people death due to self-murder, of which, anxiety disorders and depression are a prime cause. The rising demand for the antidepressants can be attributed to the growth of the market.

Free TOC of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/anxiety-disorders-and-depression-treatment-market/#ulp-c654SbFYO64MsOhu

Market Scope: Anxiety Disorders and Depression Treatment Market

Anxiety disorders and depression treatment market is segmented based on the product type and distribution channel

Based on the product type, the market is segmented into the following:

• MAOIs (Monoamine Oxidase inhibitors)

• Atypical Antipsychotics

• Benzodiazepines

• Anticonvulsants

• Beta-Blockers

• SRIs (Selective Serotonin Reuptake Inhibitors)

• SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

• TeCAs (Tetracyclic Antidepressants)

• TCAs (Tricyclic Antidepressants)

• Others

Need more information about this report @

www.precisionbusinessinsights.com/market-reports/anxiety-disorders-and-depression-treatment-market/#ulp-14mlyhjMGhVjZqa3

Regional Analysis: Anxiety Disorders and Depression Treatment Market

Geographically, global anxiety disorders and depression treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America anxiety disorders and depression treatment market is the dominant market when compared with that of the other regional markets. According to the National Alliance on Mental Illness, Anxiety disorders are the most common mental health concern in the United States.

Competition Assessment: Anxiety Disorders and Depression Treatment Market

Some of the players in the global anxiety disorders and depression treatment market include:

• Eli Lilly and Company (U.S)

• H. Lundbeck A/S (Denmark)

• AstraZeneca (UK)

• Merck and Company, Inc. (U.S)

• Johnson and Johnson (U.S)

• Sanofi-Aventis (France)

• GlaxoSmithKline plc (UK)

• Pfizer, Inc. (U.S)

Get access to full summary @

www.precisionbusinessinsights.com/market-reports/anxiety-disorders-and-depression-treatment-market/

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2013 Proserve Technology, Inc.